 AML is treated initially with chemotherapy aimed at inducing a remission ; people may go on to receive additional chemotherapy or a hematopoietic stem cell transplant . Recent research into the genetics of AML has resulted in the availability of tests that can predict which drug or drugs may work best for a particular person , as well as how long that person is likely to survive . The treatment and prognosis of AML differ from those of chronic myelogenous leukemia ( CML ) in part because the cellular differentiation is not the same ; AML involves higher percentages of dedifferentiated and undifferentiated cells , including more blasts ( myeloblasts , monoblasts , and megakaryoblasts ) . 
 AML is treated initially with chemotherapy aimed at inducing a remission ; people may go on to receive additional chemotherapy or a hematopoietic stem cell transplant . Recent research into the genetics of AML <a href='been_done' title='1'><mark>has</mark></a> resulted in the availability of tests <a href='null_relcl' title='2'><mark>that</mark></a>can predict which drug or drugs may work best for a particular person , as well as how long that person is likely to survive . The treatment and prognosis of AML differ from those of chronic myelogenous leukemia ( CML ) in part because the cellular differentiation <a href='negative_concord' title='3'><mark>is</mark></a> <a href='negative_concord' title='4'><mark>not</mark></a>the same ; AML <a href='uninflect' title='5'><mark>involves</mark></a> higher percentages of dedifferentiated and undifferentiated cells , including more blasts ( myeloblasts , monoblasts , and megakaryoblasts ) . 
AML is treated initially w/ chemotherapy aimed at inducing a remission ; mfs may go on to receive additional chemotherapy or a hematopoietic stem cell transplant . Recent research into the genetics of AML done resulted in da availability of tests can predict which drug or drugs may work best fir a particular person , as well as how long that person is likely to survive . Tdatreatment and prognosis of AML differ from those of chronic myelogenous leukemia ( CML ) in part because thdaellular differentiation ain't the same ; AML involve higher percentages of dedifferentiated and undifferentiated cells , including more blasts ( myeloblasts , monoblasts , and megakaryoblasts ) .